HomeComparePBE vs PM

PBE vs PM: Dividend Comparison 2026

PBE yields 1.11% · PM yields 3.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PM wins by $28.4K in total portfolio value
10 years
PBE
PBE
● Live price
1.11%
Share price
$78.29
Annual div
$0.87
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.3K
Annual income
$118.95
Full PBE calculator →
PM
Philip Morris International
● Live price
3.49%
Share price
$164.83
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,502.61
Full PM calculator →

Portfolio growth — PBE vs PM

📍 PM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPBEPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PBE + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PBE pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PBE
Annual income on $10K today (after 15% tax)
$94.10/yr
After 10yr DRIP, annual income (after tax)
$101.11/yr
PM
Annual income on $10K today (after 15% tax)
$297.03/yr
After 10yr DRIP, annual income (after tax)
$2,127.22/yr
At 15% tax rate, PM beats the other by $2,026.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PBE + PM for your $10,000?

PBE: 50%PM: 50%
100% PM50/50100% PBE
Portfolio after 10yr
$35.5K
Annual income
$1,310.79/yr
Blended yield
3.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

PBE
No analyst data
Altman Z
3.7
Piotroski
3/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.9% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PBE buys
0
PM buys
0
No recent congressional trades found for PBE or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPBEPM
Forward yield1.11%3.49%
Annual dividend / share$0.87$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$21.3K$49.6K
Annual income after 10y$118.95$2,502.61
Total dividends collected$1.2K$11.8K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PBE vs PM ($10,000, DRIP)

YearPBE PortfolioPBE Income/yrPM PortfolioPM Income/yrGap
1← crossover$10,811$110.71$11,650$409.56$839.00PM
2$11,679$111.85$13,592$497.49$1.9KPM
3$12,610$112.93$15,882$605.21$3.3KPM
4$13,606$113.95$18,589$737.41$5.0KPM
5$14,674$114.92$21,794$899.94$7.1KPM
6$15,817$115.82$25,597$1,100.16$9.8KPM
7$17,041$116.68$30,118$1,347.30$13.1KPM
8$18,351$117.48$35,505$1,652.97$17.2KPM
9$19,754$118.24$41,940$2,031.88$22.2KPM
10$21,255$118.95$49,643$2,502.61$28.4KPM

PBE vs PM: Complete Analysis 2026

PBEStock

The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Full PBE Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this PBE vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PBE vs SCHDPBE vs JEPIPBE vs OPBE vs KOPBE vs MAINPBE vs MOPBE vs BTIPBE vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.